4-chloro-2-[(2-methyl-5-oxo-7,8,10,10a-tetrahydropyrido[2',3':3,4]pyrrolo[1,2-a]pyrazin-9(5H)-yl)sulfonyl]benzonitrile | 1387568-36-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 4-chloro-2-[(2-methyl-5-oxo-7,8,10,10a-tetrahydropyrido[2',3':3,4]pyrrolo[1,2-a]pyrazin-9(5H)-yl)sulfonyl]benzonitrile
• 英文别名: 4-Chloro-2-[(4-methyl-8-oxo-3,9,12-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5-trien-12-yl)sulfonyl]benzonitrile
• CAS: 1387568-36-6
• 化学式: C₁₈H₁₅ClN₄O₃S
• 分子量: 402.861
• InChiKey: ISHGCFHRCNIYSR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  103
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• [EN] PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS<br/>[FR] DÉRIVÉS DE PIPÉRAZINE EN TANT QUE BLOQUEURS DE CANAUX CALCIQUES CAV2.2
  申请人：CONVERGENCE PHARMACEUTICALS

  公开号：WO2012098400A1

  公开（公告）日：2012-07-26

  The invention relates to novel piperazine compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.

  这项发明涉及新型哌嗪化合物；它们的制备方法；含有这些化合物的药物组合物；以及利用这些化合物在治疗中阻断Cav2.2钙通道对有益的疾病进行治疗，即特别用于治疗疼痛。
• PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS
  申请人：Norton David

  公开号：US20140038976A1

  公开（公告）日：2014-02-06

  The invention relates to novel piperazine compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Ca v 2.2 calcium channels is beneficial, i.e. in particular to treat pain.

  本发明涉及新型哌嗪化合物；其制备方法；含有该化合物的制药组合物；以及将该化合物用于治疗阻断Cav2.2钙通道有益的疾病的治疗中，即特别用于治疗疼痛。
• US8933132B2
  申请人：——

  公开号：US8933132B2

  公开（公告）日：2015-01-13